Sarah Li - Nov 16, 2022 Form 3 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
VP, Accounting and Controller
Signature
/s/ Eric A. Adams, by power-of-attorney for Ms. Sarah Li
Stock symbol
INM
Transactions as of
Nov 16, 2022
Transactions value $
$0
Form type
3
Date filed
11/29/2022, 05:58 PM
Next filing
Dec 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INM Employee Stock Option (Right to Buy) Nov 16, 2022 Common shares 242 $151.90 Direct F1
holding INM Employee Stock Option (Right to Buy) Nov 16, 2022 Common shares 80 $70.89 Direct F2
holding INM Employee Stock Option (Right to Buy) Nov 16, 2022 Common shares 80 $35.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from Canadian exercise price of C$206.25 using an exchange rate of C$1.3578 = US$1.00
F2 Converted from Canadian exercise price of C$96.25 using an exchange rate of C$1.3578 = US$1.00
F3 60 of the options have vested, 20 options will vest on Dec 16, 2022.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney